Galvus met 1000/50 x60
Galvus Met 1000/50mg x60 is a prescription medication combining vildagliptin and metformin, used to manage type 2 diabetes. Widely used in Nigeria, it helps regulate blood sugar levels, improve insulin sensitivity, reduce glucose production, and support overall glycemic control when taken as prescribed by a healthcare professional.
Galvus® Met 1000/50 Tablets x60 – Novartis Pharmaceuticals
Galvus Met® combines vildagliptin 100mg and metformin 50mg in a single tablet to manage type 2 diabetes mellitus. Vildagliptin is a DPP-4 inhibitor that enhances insulin secretion, while metformin improves insulin sensitivity and reduces hepatic glucose production. Together, they help maintain healthy blood sugar levels.
Key Benefits:
- Supports effective blood glucose control in type 2 diabetes
- Combines two complementary mechanisms in one tablet
- Reduces post-meal blood sugar spikes
- Convenient once- or twice-daily dosing
- Helps improve overall glycemic management
Typical Uses:
- Management of type 2 diabetes mellitus in adults
- Used when diet, exercise, and monotherapy are insufficient
- Helps prevent long-term complications of uncontrolled diabetes
Directions for Use:
Take one tablet as prescribed by your healthcare professional, usually with meals to reduce gastrointestinal side effects. Follow your doctor’s instructions regarding diet, exercise, and monitoring of blood sugar.
Storage:
Store in a cool, dry place below 30°C. Keep out of reach of children.
Important Information:
- Use only under medical supervision
- Possible side effects include nausea, diarrhea, headache, or hypoglycemia (low blood sugar)
- Monitor kidney function and blood glucose regularly
- Consult your doctor if symptoms persist, worsen, or if you experience signs of lactic acidosis







